PPARα activation sensitizes cancer cells to epigallocatechin-3-gallate (EGCG) treatment via suppressing heme oxygenase-1. (Q39032412)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 January 2014
edit
Language Label Description Also known as
English
PPARα activation sensitizes cancer cells to epigallocatechin-3-gallate (EGCG) treatment via suppressing heme oxygenase-1.
scientific article published on 21 January 2014

    Statements

    PPARα activation sensitizes cancer cells to epigallocatechin-3-gallate (EGCG) treatment via suppressing heme oxygenase-1. (English)
    Shuyu Zhang
    Xiaodong Yang
    Judong Luo
    Wanping Sun
    Hong Zhu
    Weiping Zhang
    Jianping Cao
    Yinglong Hou
    21 January 2014
    315-324

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit